1. Home
  2. OTH vs KRRO Comparison

OTH vs KRRO Comparison

Compare OTH & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

OTH

Off The Hook YS Inc.

N/A

Current Price

$2.61

Market Cap

67.2M

Sector

Industrials

ML Signal

N/A

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

HOLD

Current Price

$11.77

Market Cap

105.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OTH
KRRO
Founded
2012
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
67.2M
105.0M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
OTH
KRRO
Price
$2.61
$11.77
Analyst Decision
Strong Buy
Analyst Count
0
12
Target Price
N/A
$47.10
AVG Volume (30 Days)
22.0K
150.3K
Earning Date
01-01-0001
06-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
82.35
EPS
N/A
N/A
Revenue
N/A
$2,271,000.00
Revenue This Year
N/A
$145.97
Revenue Next Year
N/A
N/A
P/E Ratio
$600.18
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.95
$5.20
52 Week High
$3.75
$55.89

Technical Indicators

Market Signals
Indicator
OTH
KRRO
Relative Strength Index (RSI) 52.44 50.28
Support Level $2.03 $10.55
Resistance Level $2.72 $12.54
Average True Range (ATR) 0.22 0.85
MACD 0.01 -0.06
Stochastic Oscillator 88.24 41.26

Price Performance

Historical Comparison
OTH
KRRO

About OTH Off The Hook YS Inc.

Off The Hook YS Inc operates as a nationwide leader in the yacht and boat dealership industry, offering a comprehensive suite of services that spans the entire boat value chain. The company operates as two segments: Boat Sales and Azure Funding. Boat Sales includes Specializing in the buying, selling, and wholesaling of yachts and boats, having a boat dealership created to run Yellow Fin sales in Miami; and Azure Funding includes a recreational loan broker and lender providing financing solutions for individuals, dealerships, and brokerages.

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

Share on Social Networks: